HPV vaccine, also known as cervical cancer vaccine, is used to prevent cervical cancer caused by human papillomavirus. There are bivalent vaccines, tetravalent vaccines and nine-valent vaccines. Vaccination of anti-HPV vaccine generally requires cash payment at the inoculation hospital, and bivalent vaccine and tetravalent vaccine can also be paid by medical insurance card. Nine-valent vaccine has different regulations in different regions, but it can also be paid by medical insurance in most places. The bivalent vaccine is suitable for women aged 9-45, and has preventive effect on most cervical cancers and related precancerous lesions. Tetravalent vaccine is suitable for women aged 20-45, and has preventive effect on most cervical cancer and precancerous lesions, condyloma acuminatum in anus and reproductive organs. The nine-valent vaccine is suitable for women aged 16-26, and has a preventive effect on most cervical cancer and precancerous lesions, condyloma acuminatum in anus and reproductive organs, which is stronger than the four-valent vaccine.
At present, cervical cancer vaccination is basically self-funded, which can be paid by medical insurance card, but it will not be reimbursed. Although the cervical cancer vaccine is expensive, it has a significant preventive effect on cervical cancer. It is recommended that female friends actively vaccinate.